BCAS1 anticorps (N-Term)

N° du produit ABIN950616

Détail du produit anti-BCAS1 anticorps

Antigène: BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))

Épitope: AA 1-30, N-Term

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp BCAS1 est non-conjugé

Application: Western Blotting (WB), Enzyme Immunoassay (EIA)

Specificité: This antibody reacts to BCAS1.

Réactivité croisée (Details): Species reactivity (tested):Human.

Purification: Affinity chromatography on Protein A

Immunogène: KLH conjugated synthetic peptide between 1-30 amino acids from the N-terminal region of human BCAS1

Isotype: Ig Fraction

Information d'application

Indications d'application: Optimal working dilution should be determined by the investigator.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.25 mg/mL

Buffer: PBS containing 0.09 % (W/V) sodium azide as preservative

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: 4 °C/-20 °C

Stockage commentaire: Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.

Détails sur BCAS1

Antigène: BCAS1 (Breast Carcinoma Amplified Sequence 1 (BCAS1))

Autre désignation: BCAS1 / NABC1 (BCAS1 Produits)

Synonymes: anticorps AIBC1, anticorps NABC1, anticorps 2210416M21Rik, anticorps 9030223A09Rik, anticorps AI841227, anticorps Band83, anticorps Pmes-2, anticorps BCAS1, anticorps MGC152145, anticorps breast carcinoma amplified sequence 1, anticorps BCAS1, anticorps Bcas1

Sujet: This gene resides in a region at 20q13 which is amplified in a variety of tumor types and associated with more aggressive tumor phenotypes. Among the genes identified from this region, it was found to be highly expressed in three amplified breast cancer cell lines and in one breast tumor without amplification at 20q13.2. However, this gene is not in the common region of maximal amplification and its expression was not detected in the breast cancer cell line MCF7, in which this region is highly amplified. Although not consistently expressed, this gene is a candidate oncogene.Synonyms: AIBC1, Breast carcinoma-amplified sequence 1

ID gène: 8537

NCBI Accession: NP_003648